Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. (Q40609797)

22 September 2017

title

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. (English)

1 reference

22 September 2017

1 reference

Takayuki Yamada

1

1 reference

22 September 2017

Koichi Sato

2

1 reference

22 September 2017

Mayumi Komachi

3

1 reference

22 September 2017

Enkhzol Malchinkhuu

4

1 reference

22 September 2017

Masayuki Tobo

5

1 reference

22 September 2017

Takao Kimura

6

1 reference

22 September 2017

Atsushi Kuwabara

7

1 reference

22 September 2017

Yasuhiro Yanagita

8

1 reference

22 September 2017

Toshiro Ikeya

9

1 reference

22 September 2017

Yoshifumi Tanahashi

10

1 reference

22 September 2017

Tetsushi Ogawa

11

1 reference

22 September 2017

Susumu Ohwada

12

1 reference

22 September 2017

Yasuo Morishita

13

1 reference

22 September 2017

Hideo Ohta

14

1 reference

22 September 2017

Doon-Soon Im

15

1 reference

22 September 2017

Koichi Tamoto

16

1 reference

22 September 2017

Hideaki Tomura

17

1 reference

22 September 2017

Fumikazu Okajima

18

1 reference

22 September 2017

language of work or name

English

0 references

publication date

3 December 2003

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

279

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

6595-6605

1 reference

The National Cancer Data Base report on pancreatic cancer

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Bioactive lysophospholipids and their G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Lysophosphatidic acid as a novel cell survival/apoptotic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Lysophosphatidic acid as an autocrine and paracrine mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Malignant effusions contain lysophosphatidic acid (LPA)-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Growth dependency of a new human pancreatic cancer cell line, YAPC, on autocrine interleukin-1alpha stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308133200

21 January 2018

Identifiers

DOI

10.1074/JBC.M308133200

1 reference

22 September 2017

1 reference